A Practical Approach to Clinical Antibiotic Stewardship in the ICU Patient with Severe Infection
暂无分享,去创建一个
[1] M. Hameed,et al. Comparison of 8 VS. 15 Days of Antibiotic Therapy for Ventilator-Associated Pneumonia in Adults: A Randomized Trial , 2019 .
[2] Matthijs S. Berends,et al. Rapid Analysis of Diagnostic and Antimicrobial Patterns in R (RadaR): Interactive Open-Source Software App for Infection Management and Antimicrobial Stewardship , 2019, Journal of medical Internet research.
[3] S. Cosgrove,et al. Antibiotic Therapy for Pseudomonas aeruginosa Bloodstream Infections: How Long is Long Enough? , 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[4] E. Mylonakis,et al. A Systematic Review and Meta-analysis of Antibiotic Treatment Duration for Bacteremia Due to Enterobacteriaceae , 2019, Antimicrobial Agents and Chemotherapy.
[5] M. Kollef,et al. Rationalizing antimicrobial therapy in the ICU: a narrative review , 2019, Intensive Care Medicine.
[6] Emmanuel O Irek,et al. A systematic review of healthcare-associated infections in Africa: An antimicrobial resistance perspective , 2018, African journal of laboratory medicine.
[7] M. Bassetti,et al. Risk stratification and treatment of ICU-acquired pneumonia caused by multidrug- resistant/extensively drug-resistant/pandrug-resistant bacteria , 2018, Current opinion in critical care.
[8] Johan Decruyenaere,et al. A complete and multifaceted overview of antibiotic use and infection diagnosis in the intensive care unit: results from a prospective four-year registration , 2018, Critical Care.
[9] S. Tschudin-Sutter,et al. Combination therapy for treatment of Pseudomonas aeruginosa bloodstream infections , 2018, PloS one.
[10] S. Beatson,et al. Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial , 2018, JAMA.
[11] E. Mylonakis,et al. Systematic Review and Meta-analysis of the Efficacy of Short-Course Antibiotic Treatments for Community-Acquired Pneumonia in Adults , 2018, Antimicrobial Agents and Chemotherapy.
[12] Herman Goossens,et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. , 2018, The Lancet. Global health.
[13] C. Mcnulty,et al. Treatment of infections caused by multidrug-resistant Gram-negative bacteria: report of the British Society for Antimicrobial Chemotherapy/Healthcare Infection Society/British Infection Association Joint Working Party† , 2018, The Journal of antimicrobial chemotherapy.
[14] F. Tubach,et al. Short-course antibiotic therapy for critically ill patients treated for postoperative intra-abdominal infection: the DURAPOP randomised clinical trial , 2018, Intensive Care Medicine.
[15] Kerri A. Thom,et al. Risk Factors and Outcomes Associated with Multidrug-Resistant Acinetobacter baumannii upon Intensive Care Unit Admission , 2017, Antimicrobial Agents and Chemotherapy.
[16] M. Hulscher,et al. Antibiotic stewardship: does it work in hospital practice? A review of the evidence base. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[17] H. Goossens,et al. Is there any difference in quality of prescribing between antibacterials and antifungals? Results from the first global point prevalence study (Global PPS) of antimicrobial consumption and resistance from 53 countries , 2017, The Journal of antimicrobial chemotherapy.
[18] M. Rybak,et al. Multidrug-resistant Pseudomonas aeruginosa lower respiratory tract infections in the intensive care unit: Prevalence and risk factors. , 2017, Diagnostic microbiology and infectious disease.
[19] R. Wunderink,et al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia , 2017, European Respiratory Journal.
[20] S. Nseir,et al. Colonization pressure as a risk factor of ICU-acquired multidrug resistant bacteria: a prospective observational study , 2017, European Journal of Clinical Microbiology & Infectious Diseases.
[21] B. Nathanson,et al. Carbapenem resistance, inappropriate empiric treatment and outcomes among patients hospitalized with Enterobacteriaceae urinary tract infection, pneumonia and sepsis , 2017, BMC Infectious Diseases.
[22] J. Fishman. Infection in Organ Transplantation , 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[23] M. Ciotti,et al. Rapid detection of carbapenemase-producing Klebsiella pneumoniae strains derived from blood cultures by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS) , 2017, BMC Microbiology.
[24] H. Schünemann,et al. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update , 2017, European Respiratory Journal.
[25] Sangeeta Mehta,et al. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016 , 2017, Intensive Care Medicine.
[26] S. Michie,et al. Interventions to improve antibiotic prescribing practices for hospital inpatients. , 2017, The Cochrane database of systematic reviews.
[27] Kai Zhou,et al. Application of next generation sequencing in clinical microbiology and infection prevention. , 2017, Journal of biotechnology.
[28] R. Weinstein,et al. Antimicrobial Stewardship: How the Microbiology Laboratory Can Right the Ship , 2016, Clinical Microbiology Reviews.
[29] C. Thomson,et al. Management of Adults with Hospital-acquired and Ventilator-associated Pneumonia. , 2016, Annals of the American Thoracic Society.
[30] M. Paul,et al. Antibiotic de-escalation for bloodstream infections and pneumonia: systematic review and meta-analysis. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[31] S. Richter,et al. The presence of a single MALDI-TOF mass spectral peak predicts methicillin resistance in staphylococci. , 2016, Diagnostic microbiology and infectious disease.
[32] Ying Guo,et al. De-escalation of empiric antibiotics in patients with severe sepsis or septic shock: A meta-analysis. , 2016, Heart & lung : the journal of critical care.
[33] D. Niven,et al. Pyrexia: aetiology in the ICU , 2016, Critical Care.
[34] P. Fey,et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[35] D. Denning,et al. Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[36] J. Dorca,et al. Declining mortality among hospitalized patients with community-acquired pneumonia. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[37] Matthew H Samore,et al. Implementing an Antibiotic Stewardship Program: Guidelines by the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[38] J. Timsit,et al. A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[39] T. van der Poll,et al. Incidence, Risk Factors, and Attributable Mortality of Secondary Infections in the Intensive Care Unit After Admission for Sepsis. , 2016, JAMA.
[40] B. Jia,et al. Resistance trends among clinical isolates in China reported from CHINET surveillance of bacterial resistance, 2005-2014. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[41] Keith M Olsen,et al. A Multicenter Evaluation of Prolonged Empiric Antibiotic Therapy in Adult ICUs in the United States* , 2015, Critical care medicine.
[42] S. Micek,et al. Inadequate Source Control and Inappropriate Antibiotics are Key Determinants of Mortality in Patients with Intra-Abdominal Sepsis and Associated Bacteremia. , 2015, Surgical infections.
[43] James H Derzon,et al. Effectiveness of Practices To Increase Timeliness of Providing Targeted Therapy for Inpatients with Bloodstream Infections: a Laboratory Medicine Best Practices Systematic Review and Meta-analysis , 2015, Clinical Microbiology Reviews.
[44] B. Iung,et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). , 2015, European heart journal.
[45] S. Crawford,et al. Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation. , 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
[46] D. Ecker,et al. Rapid Diagnosis of Infection in the Critically Ill, a Multicenter Study of Molecular Detection in Bloodstream Infections, Pneumonia, and Sterile Site Infections* , 2015, Critical care medicine.
[47] M. Puskarich,et al. The Impact of Timing of Antibiotics on Outcomes in Severe Sepsis and Septic Shock: A Systematic Review and Meta-Analysis* , 2015, Critical care medicine.
[48] S. Seo,et al. Antimicrobial de-escalation in septic cancer patients: is it safe to back down? , 2015, Intensive Care Medicine.
[49] D. Trapani,et al. Antibiotic treatment strategies for community-acquired pneumonia in adults , 2015, Internal and Emergency Medicine.
[50] Y. Golan. Empiric therapy for hospital-acquired, Gram-negative complicated intra-abdominal infection and complicated urinary tract infections: a systematic literature review of current and emerging treatment options , 2015, BMC Infectious Diseases.
[51] P. Lipsett,et al. Trial of short-course antimicrobial therapy for intraabdominal infection. , 2015, The New England journal of medicine.
[52] M. Antonelli,et al. A multicenter multinational study of abdominal candidiasis: epidemiology, outcomes and predictors of mortality , 2015, Intensive Care Medicine.
[53] F. Tubach,et al. Performance and impact of a rapid method combining mass spectrometry and direct antimicrobial susceptibility testing on treatment adequacy of patients with ventilator-associated pneumonia. , 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[54] J. Garnacho-Montero,et al. Antibiotic de-escalation in the ICU: how is it best done? , 2015, Current opinion in infectious diseases.
[55] W. Boersma,et al. Antibiotic treatment strategies for community-acquired pneumonia in adults. , 2015, The New England journal of medicine.
[56] T. Welte,et al. Preventive and therapeutic strategies in critically ill patients with highly resistant bacteria , 2015, Intensive Care Medicine.
[57] M. Dupon,et al. Antibiotic treatment for 6 weeks versus 12 weeks in patients with pyogenic vertebral osteomyelitis: an open-label, non-inferiority, randomised, controlled trial , 2015, The Lancet.
[58] L. Decosterd,et al. A simple, robust and rapid approach to detect carbapenemases in Gram-negative isolates by MALDI-TOF mass spectrometry: validation with triple quadripole tandem mass spectrometry, microarray and PCR. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[59] C. Spies,et al. Long-term effect of computer-assisted decision support for antibiotic treatment in critically ill patients: a prospective ‘before/after’ cohort study , 2014, BMJ Open.
[60] T. Perneger,et al. β-Lactam monotherapy vs β-lactam-macrolide combination treatment in moderately severe community-acquired pneumonia: a randomized noninferiority trial. , 2014, JAMA internal medicine.
[61] J. Garnacho-Montero,et al. How to treat VAP due to MDR pathogens in ICU patients , 2014, BMC Infectious Diseases.
[62] J. D. De Waele,et al. How to treat infections in a surgical intensive care unit , 2014, BMC Infectious Diseases.
[63] Arjun Srinivasan,et al. Core elements of hospital antibiotic stewardship programs from the Centers for Disease Control and Prevention. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[64] G. Forrest,et al. Use of electronic health records and clinical decision support systems for antimicrobial stewardship. , 2014, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[65] Blake W Buchan,et al. Emerging Technologies for the Clinical Microbiology Laboratory , 2014, Clinical Microbiology Reviews.
[66] J. Chastre,et al. Antibiotic stewardship in the intensive care unit , 2014, Critical Care.
[67] K. Baumstarck,et al. De-escalation versus continuation of empirical antimicrobial treatment in severe sepsis: a multicenter non-blinded randomized noninferiority trial , 2014, Intensive Care Medicine.
[68] M. Levy,et al. Empiric Antibiotic Treatment Reduces Mortality in Severe Sepsis and Septic Shock From the First Hour: Results From a Guideline-Based Performance Improvement Program* , 2014, Critical care medicine.
[69] B. Gadeyne,et al. Development of antibiotic treatment algorithms based on local ecology and respiratory surveillance cultures to restrict the use of broad-spectrum antimicrobial drugs in the treatment of hospital-acquired pneumonia in the intensive care unit: a retrospective analysis , 2014, Critical Care.
[70] Bing Li,et al. β-Lactam/macrolide dual therapy versus β-lactam monotherapy for the treatment of community-acquired pneumonia in adults: a systematic review and meta-analysis. , 2014, The Journal of antimicrobial chemotherapy.
[71] K. Mehta,et al. Burden of antibiotic resistance in common infectious diseases: role of antibiotic combination therapy. , 2014, Journal of clinical and diagnostic research : JCDR.
[72] James J. Cimino,et al. A Rapid Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry-Based Method for Single-Plasmid Tracking in an Outbreak of Carbapenem-Resistant Enterobacteriaceae , 2014, Journal of Clinical Microbiology.
[73] M. P. Gómez,et al. International Registry in Organ Donation and Transplantation--2013. , 2014, Transplantation proceedings.
[74] J. Rello,et al. How to approach and treat VAP in ICU patients , 2014, BMC Infectious Diseases.
[75] M. Ison,et al. Nosocomial infections within the first month of solid organ transplantation , 2014, Transplant infectious disease : an official journal of the Transplantation Society.
[76] J. Knudsen,et al. Clinical consequences of using PNA-FISH in Staphylococcal bacteraemia , 2014, European Journal of Clinical Microbiology & Infectious Diseases.
[77] J. Marshall,et al. Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study , 2014, Critical Care.
[78] M. F. Parry,et al. Successful reduction in catheter-associated urinary tract infections: focus on nurse-directed catheter removal. , 2013, American journal of infection control.
[79] D. Livermore,et al. European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia , 2013, Haematologica.
[80] J. Knudsen,et al. Clinical consequences of using PNA-FISH in Staphylococcal bacteraemia , 2013, European Journal of Clinical Microbiology & Infectious Diseases.
[81] L. Nace,et al. Factors influencing the implementation of antibiotic de-escalation and impact of this strategy in critically ill patients , 2013, Critical Care.
[82] D. Jacobs,et al. Evaluating the impact of a pharmacist's absence from an antimicrobial stewardship team. , 2013, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[83] C. Destache,et al. Does Antibiotic De-escalation for Nosocomial Pneumonia Impact Intensive Care Unit Length of Stay? , 2013 .
[84] M. Falagas,et al. β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis. , 2013, International journal of antimicrobial agents.
[85] A. Torres,et al. A week seems to be weak: tailoring duration of antibiotic treatment in Gram-negative ventilator-associated pneumonia , 2013, Critical Care.
[86] J. L. Kendall,et al. Locally derived versus guideline-based approach to treatment of hospital-acquired pneumonia in the trauma intensive care unit. , 2012, Surgical infections.
[87] M. Baker,et al. Risk factors, microbiological findings and outcomes of necrotizing fasciitis in New Zealand: a retrospective chart review , 2012, BMC Infectious Diseases.
[88] Filip De Turck,et al. COSARA: Integrated Service Platform for Infection Surveillance and Antibiotic Management in the ICU , 2012, Journal of Medical Systems.
[89] R. Sawyer,et al. Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. , 2012, The Lancet. Infectious diseases.
[90] Pranita D. Tamma,et al. Combination Therapy for Treatment of Infections with Gram-Negative Bacteria , 2012, Clinical Microbiology Reviews.
[91] M. Büchler,et al. Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial. , 2012, JAMA.
[92] A. Boyer,et al. Direct testing of bronchoalveolar lavages from ventilator-associated pneumonia patients. , 2012, Diagnostic microbiology and infectious disease.
[93] Y. Mehta,et al. International Nosocomial Infection Control Consortium (INICC) report, data summary of 36 countries, for 2004-2009. , 2012, American journal of infection control.
[94] Frédérique Jacobs,et al. Antibiotic strategies in severe nosocomial sepsis: Why do we not de-escalate more often?* , 2012, Critical care medicine.
[95] B. Latenser,et al. Trends in 393 necrotizing acute soft tissue infection patients 2000-2008. , 2012, Burns : journal of the International Society for Burn Injuries.
[96] R. Fowler,et al. Duration of antibiotic therapy for bacteremia: a systematic review and meta-analysis , 2011, Critical care.
[97] A. Armaganidis,et al. Comparison of direct antimicrobial susceptibility testing methods for rapid analysis of bronchial secretion samples in ventilator-associated pneumonia. , 2011, International journal of antimicrobial agents.
[98] M. Kollef,et al. Antibiotic stewardship in the intensive care unit. , 2011, Seminars in respiratory and critical care medicine.
[99] J. Ramirez,et al. Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study. , 2011, The Lancet. Infectious diseases.
[100] J. Bion,et al. International standards for programmes of training in intensive care medicine in Europe , 2011, Intensive Care Medicine.
[101] Eli N. Perencevich,et al. Central Line Bundle Implementation in US Intensive Care Units and Impact on Bloodstream Infections , 2011, PloS one.
[102] J. Morel,et al. De-escalation as part of a global strategy of empiric antibiotherapy management. A retrospective study in a medico-surgical intensive care unit , 2010, Critical care.
[103] C. Spies,et al. Computer-Assisted Decision Support for Changing Practice in Severe Sepsis and Septic Shock , 2010, The Journal of international medical research.
[104] Anand Kumar,et al. A survival benefit of combination antibiotic therapy for serious infections associated with sepsis and septic shock is contingent only on the risk of death: A meta-analytic/meta-regression study , 2010, Critical care medicine.
[105] H. Einsele,et al. Immune reconstitution after allogeneic transplantation and expanding options for immunomodulation: an update. , 2010, Blood.
[106] M. Aapro,et al. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. , 2010, Annals of oncology : official journal of the European Society for Medical Oncology.
[107] A. Cheng,et al. Improved susceptibility of Gram-negative bacteria in an intensive care unit following implementation of a computerized antibiotic decision support system. , 2010, The Journal of antimicrobial chemotherapy.
[108] M. Boermeester,et al. A step-up approach or open necrosectomy for necrotizing pancreatitis. , 2010, The New England journal of medicine.
[109] D. Annane,et al. Combination antibiotic therapy with macrolides improves survival in intubated patients with community-acquired pneumonia , 2010, Intensive Care Medicine.
[110] J. Bartlett,et al. Diagnosis and management of complicated intra-abdominal infection in adults and children: guidelines by the Surgical Infection Society and the Infectious Diseases Society of America. , 2010, Surgical infections.
[111] Jordi Rello,et al. International study of the prevalence and outcomes of infection in intensive care units. , 2009, JAMA.
[112] C. A. Bond,et al. Clinical and economic outcomes of involving pharmacists in the direct care of critically ill patients with infections* , 2008, Critical care medicine.
[113] G. Suh,et al. Impact of de-escalation therapy on clinical outcomes for intensive care unit-acquired pneumonia , 2008, Critical care.
[114] Shu-Wen Lin,et al. Impact of mecA Gene Testing and Intervention by Infectious Disease Clinical Pharmacists on Time to Optimal Antimicrobial Therapy for Staphylococcus aureus Bacteremia at a University Hospital , 2008, Journal of Clinical Microbiology.
[115] J. Fishman. Infection in solid-organ transplant recipients. , 2007, The New England journal of medicine.
[116] E. Bouza,et al. Evaluation of direct E-test on lower respiratory tract samples: a rapid and accurate procedure for antimicrobial susceptibility testing. , 2007, Diagnostic microbiology and infectious disease.
[117] T. Karchmer,et al. Using local microbiologic data to develop institution-specific guidelines for the treatment of hospital-acquired pneumonia. , 2006, Chest.
[118] K. Wood,et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock* , 2006, Critical care medicine.
[119] Karin A Thursky,et al. Reduction of broad-spectrum antibiotic use with computerized decision support in an intensive care unit. , 2006, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[120] E. Coiera,et al. Application of Information Technology: Handheld Computer-based Decision Support Reduces Patient Length of Stay and Antibiotic Prescribing in Critical Care , 2005, J. Am. Medical Informatics Assoc..
[121] Chien-Wei Hsu,et al. Catheter-Associated Urinary Tract Infections in Intensive Care Units Can Be Reduced by Prompting Physicians to Remove Unnecessary Catheters , 2004, Infection Control & Hospital Epidemiology.
[122] Leonard Leibovici,et al. β lactam monotherapy versus β lactam-aminoglycoside combination therapy for sepsis in immunocompetent patients: systematic review and meta-analysis of randomised trials , 2004, BMJ : British Medical Journal.
[123] Michel Wolff,et al. Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. , 2003, JAMA.
[124] S. Mulier,et al. Factors Affecting Mortality in Generalized Postoperative Peritonitis: Multivariate Analysis in 96 Patients , 2003, World Journal of Surgery.
[125] V L Yu,et al. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. , 2000, American journal of respiratory and critical care medicine.
[126] M. Huycke,et al. Outcomes of an antimicrobial control program in a teaching hospital. , 2000, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.
[127] C. Ohmann,et al. Risk factors associated with intraabdominal infections: a prospective multicenter study , 1999, Langenbeck's Archives of Surgery.
[128] Robert Sitton. On Europe , 1992, Current History.
[129] R A SHOOTER,et al. Antibiotic Therapy , 1959, Proceedings of the Royal Society of Medicine.
[130] J. Turnidge,et al. Australian Group on Antimicrobial Resistance (AGAR) Australian Staphylococcus aureus Sepsis Outcome Programme (ASSOP) Annual Report 2015. , 2018, Communicable diseases intelligence.
[131] T. Gottlieb,et al. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme(GNSOP) Annual Report 2015. , 2018, Communicable diseases intelligence.
[132] T. Gottlieb,et al. Australian Group on Antimicrobial Resistance (AGAR) Australian Gram-negative Sepsis Outcome Programme (GNSOP) Annual Report 2016. , 2018, Communicable diseases intelligence.
[133] R. Sawyer. Trial of Short-Course Antimicrobial Therapy for Intraabdominal Infection. , 2018, The New England journal of medicine.
[134] O. Zusman,et al. Polymyxin monotherapy or in combination against carbapenem-resistant bacteria: systematic review and meta-analysis , 2017, The Journal of antimicrobial chemotherapy.
[135] A. DeMaria,et al. The Critical Role of the Staff Nurse in Antimicrobial Stewardship--Unrecognized, but Already There. , 2016, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[136] J. Waele,et al. Reducing Antibiotic Use in the ICU: A Time-Based Approach to Rational Antimicrobial Use , 2016 .
[137] N. Dean,et al. Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model. , 2015, Respiratory medicine.
[138] G. Perkins,et al. Accuracy of LightCycler® SeptiFast for the detection and identification of pathogens in the blood of patients with suspected sepsis: a systematic review and meta-analysis , 2014, Intensive Care Medicine.
[139] E. Akl,et al. Duration of treatment , 2014 .
[140] J. Garnacho-Montero,et al. De-escalation of empirical therapy is associated with lower mortality in patients with severe sepsis and septic shock , 2013, Intensive Care Medicine.
[141] J. Blache,et al. De-escalation of antimicrobial treatment in neutropenic patients with severe sepsis: results from an observational study , 2013, Intensive Care Medicine.
[142] Vimla L. Patel,et al. Understanding the nature of information seeking behavior in critical care: Implications for the design of health information technology , 2013, Artif. Intell. Medicine.
[143] J. Bartlett,et al. Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[144] Jay Steingrub,et al. International study of the prevalence and outcomes of infection in intensive care units , 2009 .
[145] S. Seo,et al. A multidisciplinary approach to antimicrobial stewardship: evolution into the 21st century. , 2005, International journal of antimicrobial agents.
[146] Ruth Richardson,et al. A Necessary Inhumanity? , 2000, Medical humanities.
[147] K. Sepkowitz,et al. IDSA GUIDELINES Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America , 2022 .